Sulfonylurea and non-sulfonylurea hypoglycemic agents: pharmachological properties and tissue selectivity

Cook, 1988, ATP-sensitive K+ channels in pancreatic beta-cells. Spare-channel hypothesis, Diabetes, 37, 495, 10.2337/diab.37.5.495 Noma, 1983, ATP-regulated K+ channels in cardiac muscle, Nature, 305, 147, 10.1038/305147a0 Standen, 1989, Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle, Science, 245, 177, 10.1126/science.2501869 Ashcroft, 1988, Properties of single potassium channels modulated by glucose in rat pancreatic beta-cells, J. Physiol, 400, 501, 10.1113/jphysiol.1988.sp017134 Inagaki, 1995, Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor, Science, 270, 1166, 10.1126/science.270.5239.1166 Chutkow, 1996, Cloning, tissue expression, and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle, and vascular KATP channels, Diabetes, 45, 1439, 10.2337/diab.45.10.1439 Inagaki, 1996, A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels, Neuron, 16, 1011, 10.1016/S0896-6273(00)80124-5 Isomoto, 1996, A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channel, J. Biol. Chem, 271, 24321, 10.1074/jbc.271.40.24321 Miki, 1997, Abnormalities of pancreatic islets by targeted expression of a dominant-negative KATP channel, Proc. Natl. Acad. Sci. U.S.A, 94, 11969, 10.1073/pnas.94.22.11969 Miki, 1998, Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice, Proc. Natl. Acad. Sci. U.S.A, 95, 10402, 10.1073/pnas.95.18.10402 Sunaga, 2001, The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide, Eur. J. Pharmacol, 431, 119, 10.1016/S0014-2999(01)01412-1 Ashfield, 1999, Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel, Diabetes, 48, 1341, 10.2337/diabetes.48.6.1341 Mikhailov, 2001, Molecular structure of the glibenclamide binding site of the beta-cell K(ATP) channel, FEBS Lett, 499, 154, 10.1016/S0014-5793(01)02538-8 Hansen, 2002, Differential interactions of nateglinide and repaglinide on the human beta-cell sulphonylurea receptor 1, Diabetes, 51, 2789, 10.2337/diabetes.51.9.2789 Suzuki, 2002, Role of sarcolemmal K(ATP) channels in cardioprotection against ischemia/reperfusion injury in mice, J. Clin. Invest, 109, 509, 10.1172/JCI0214270 Lee, 2003, Impairment of myocardial protection in type 2 diabetic patients, J. Clin. Endocrinol. Metab, 88, 531, 10.1210/jc.2002-020904 UK Prospective Diabetes Study (UKPDS) Group, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet 352 (1998) 837–853.